key: cord-0717652-w4p173ce
authors: nan
title: Full Issue PDF
date: 2020-05-31
journal: JACC: Cardiovascular Imaging
DOI: 10.1016/s1936-878x(20)30301-6
sha: e4386084ac2c16660c0919c89cbb77567556c395
doc_id: 717652
cord_uid: w4p173ce

nan

. Six weeks after hospital discharge, patients were evaluated at the outpatient clinic with repeat echocardiography. In addition, the initial study cohort was followed up prospectively for the development of heart failure readmission and all-cause mortality.

The study complied with the Declaration of Helsinki, and the locally appointed ethics committee approved the research protocol. Written informed consent was obtained from every patient before any study-specific procedure was performed. Hemodynamic changes before and after decongestive therapy are summarized in Table 2 . PAWP decreased to 15 AE 7 mm Hg (p < 0.001) and central venous pressure to 6 AE 5 mm Hg (p < 0.001). The median N-terminal pro-B-type natriuretic peptide level was 3,901 pg/ml (1,825 to 8,231 pg/ml) ( Table 1) and 2,288 pg/ml (1,059 to 3,364 pg/ml) at admission and discharge, respectively. N-terminal pro-B-type natriuretic peptide levels at admission were comparable between patients with PALS after decongestion above the mean versus below the mean, although there was a trend toward lower values at discharge in the latter subgroup (p ¼ 0. 316 Thirteen patients were readmitted for immediate decompensated heart failure (n ¼ 10 vs. n ¼ 3 PALS after decongestion below and above the mean, respectively; log-rank test; p ¼ 0.030). Five patients CVP ¼ central venous pressure; DBP ¼ diastolic blood pressure; DPAP ¼ diastolic pulmonary artery pressure; MAP ¼ mean arterial pressure; MPAP ¼ mean pulmonary artery pressure; PAC ¼ pulmonary artery compliance; PAWP ¼ pulmonary artery wedge pressure; SBP ¼ systolic blood pressure; SPAP ¼ systolic pulmonary artery pressure. Ischemic cardiomyopathy 15 (48.4) died in the subgroup with lower decongested PALS, opposed to 1 in the other subgroup (log-rank test;

p ¼ 0.140). Figure 3 shows the Kaplan-Meier curve for the combined endpoint of heart failure recurrence and all-cause mortality. Baseline PALS was not predictive (p ¼ 0.471). Lower PALS values after decongestion (i.e., below the sample mean) were associated with a higher event rate (log-rank test; p < 0.019). In a forward conditional multivariable model incorpo- Table 2 ). Similarly, less recovery of PALS after decongestive therapy (ratio of delta PALS/PALS after decongestion below a median value of 33%) was associated with higher event rates (log-rank test;

p < 0.038) (Supplemental Figure 1 ). In contrast, conventional parameters such as mean E/e 0 or LA volume index after decongestion were not predictive of the combined endpoint (log-rank test; p ¼ 0.091 and p ¼ 0.067).

This study adds novel information about the effects of decongestive therapy on alterations in LA mechanical function and its association with outcomes in advanced decompensated HFrEF. Key findings of this study are, first, decongestive therapy and afterload reduction acutely improved LA reservoir function, assessed by PALS and reservoir strain rate.

Second, while immediate changes in PAWP during decongestive therapy correlated with immediate Third, PALS after decongestion was associated with PAWP, independent of LV and LA volumes. Lastly, greater improvement in PALS and a higher absolute PALS value after decongestion were independently associated with a lower risk for the composite endpoint of all-cause death or immediate heart failure recurrence. Thus, our data show that LA reservoir function is strongly impaired in immediate decompensated HFrEF but has the potential to recover in a subset of patients in the weeks after decongestive therapy, which is related to improved outcomes.

These data indicate that effective decongestion is a

prerequisite, yet no guarantee, to restore LA function. advanced HFrEF (12) and proved to be a powerful prognosticator for the composite endpoint of heart failure rehospitalization and all-cause death in these subjects (13) . Moreover, LA reservoir function at rest correlated strongly with impaired functional capacity during exercise (14) . Importantly, all of these studies have focused on LA function in stable, compensated

HFrEF. Instead, LA adaptation to pressure and volume overload has not been studied extensively. (13, 15, 16) . Six weeks after hospital discharge, an additional increase in mean LA reservoir function was found, advocating additional LA mechanical function improvement. Booster pump strain rate improved significantly only after 6 weeks.

Of note, PALS during hospitalization (both before and after decongestive therapy) was considerably lower in this study compared with previous studies reporting PALS in chronic HFrEF (13, 14) . These differences may relate to the additional insult (i.e., immediate decompensation warranting hemodynamic-guided therapy) to which the diseased left atrium is exposed. Previously, LA pressure-area relations illustrate reduced LA compliance in congestive heart failure with major effects on LA passive mechanical properties (V-loop) (17) . In progressive heart failure with a restrictive filling pattern, the left atrium transitions from a storage and contractile chamber to a basic conduit (i.e., conduit function predominates, as illustrated by the pressure-volume loop in Supplemental Figure 2 , right-sided panel) (8, 18) . Also, increased LV filling pressures (during immediate congestion) may act as a "second-hit" for LA booster pump mechanics already functioning at the tipping point of the Frank-Starling mechanism (8).

Heart failure therapy is able to decrease LV wall tension and LA afterload mismatch, which seems to relieve LA booster pump function in the failing heart (19, 20) . In addition to restoring LA preload reserve, arterial vasodilators have been shown to improve operative atrial distensibility in congestive heart failure (20) . These data are consistent with the find- This deserves to be further investigated.

The LA contributes to systolic and diastolic LV function by its reservoir, conduit, and booster pump function (5) . PALS quantifies the longitudinal expansion of the LA wall during systole and is a measure of LA reservoir function. When heart failure progresses, PALS linearly decreases. Interpretation of PALS may not always be that easy. PALS has been too long regarded as solely reflecting LV function and LA size (6, 7) . However, various determinants should be considered:

1. Longitudinal systolic LV function: during systole, the fibrotic atrioventricular ring that connects the atria and ventricles is moving toward the apex.

Therefore, the LA reservoir function is intimately related to longitudinal LV function (8) However, proper recording of the pulmonary venous flow signal requires experience and remains demanding. Hatle (Oh et al. [13] ) was also the first to indicate how failure of LA booster function affects mitral inflow and pulmonary venous signals, and therefore, assessment of diastolic function (13) . The In the present study, we explore topological data analysis (TDA) (4), a state-of-the-art data analytical approach that provides well-founded mathematical, statistical, and algorithmic methods to present the underlying geometric structures in data. It can be used in an unsupervised machine learning pipeline to compare multiple variables and clusters similar patients into nodes. A node connects with other nodes with edges if the same patients are clustered into >1 nodes. This allows us to summarize the complex data to a simple connected patient similarity network that can be visualized to attain novel insights into disease mechanisms (5, 6) . TDA has been successfully used to derive mechanistic insights from biological datasets in disciplines such as oncology, genomics, immunology, diabetes, and pre-clinical spinal cord injury (7) (8) (9) (10) (11) (12) (13) . We applied the TDA-based network analysis to detect patient similarity patterns using a cross-sectional multiparametric echocardiographic dataset. Accordingly, TDA. We applied TDA to detect patterns in multidimensional echocardiographic parameters by studying the geometrical structure obtained from the network that signified a compressed representation of high-dimensional data (5) for patient similarity analysis. The notion of expressing the shape of data using TDA was extensively validated and successfully applied to different areas of health sciences (7, (10) (11) (12) 15 ). In the created topological network, nodes represented a cluster of patients, whereas edges connected nodes that contained patients who use of the preceding statistical tests to compare patient groups within the topological network was previously performed (10, 19) . Correlations between categorical variables were computed using Goodman and Kruskal's g coefficient. The rates of hospitalization and survival were analyzed with Cox proportional hazard models, Kaplan-Meier curves, and the log-rank test. Cox proportional hazard models were constructed to elucidate independent prognostic values of region information after adjustment with ACC/AHA heart failure stage, NYHA functional class, and the MAGGIC risk score. Furthermore, to evaluate improvement of Cox proportional hazard models by adding region information to these risk predictors, integrated discrimination improvement, net reclassification improvement, and median improvement in risk score were calculated using R package survIDINRI version 1.1-1 (R Foundation, Vienna, Austria) (20, 21) .

A p value of <0.05 was considered statistically significant. We used R version 3.4.0 (R Foundation for Statistical Computing, Vienna, Austria) for all statistical analyses.

Clinical characteristics of the study population are shown in Tables 1 and 2. CONTINUUM OF CARDIAC FUNCTION. The use of TDA to create a patientÀpatient similarity network in the retrospective dataset resulted in the formation of a looped structure. After the addition of cases from the prospective data, the loop was persistent, which validated that the phenotypic network loop structure of the network model was intrinsic to the data and not an artifact. The combined network was used for discovering feature distributions and developing associations with clinical and outcome data. We noted that echocardiographic variables followed a gradually changing pattern throughout the loop ( Figure 2 Illustration, Tables 1 and 2, Supplemental   Tables 1 and 2) . Notably, progressing from the first to the fourth region, an increasing trend was seen in age and prevalence of underlying risk factors and comorbidities. LVEF remained preserved in the first to third regions; however, it was significantly reduced in the fourth region (p < 0.001). LV mass progressively increased, and diastolic function parameters progressively worsened from region I to IV.

We found a correlation between the regions and both NYHA functional classes (g ¼ 0.47; p < 0.001) and ACC/AHA stages (g ¼ 0.52; p < 0.001) in the prospective cohort, which showed more symptomatic patients in the third and fourth regions than in the first region ( Figure 3A ). The gradation of echocardiographic features while moving counterclockwise on the loop. Abbreviations as in Figure 1 .

Tokodi et al. Table 3 and Supplemental Table 3 . After predicting the region membership of patients from the secondary cohort using the random forest classifier, the same tendency was observed for the probability of MACE-related rehospitalizations in the regions as was those in the primary cohort ( Figure 4C , Supplemental Figure 3B ).

We also wanted to demonstrate whether changing the location of a patient on the loop was associated with worsening or improvement of cardiac function.

To illustrate the motion of patients on the loop, the predicted regions of the first and second echocardiograms were compared ( Figure 5 ). Both 

The notion of patient similarity is a growing idea in personalized predictive analytics to support clinical assessment (10, (22) (23) (24) (25) Abbreviations as in Tables 1 and 2 .

Tokodi et al. Tokodi et al. is a discipline in mathematics that studies shapes. One of the key ideas in topology is that the properties of shapes are invariant (i.e., unchanging) when deformed (e.g., a circle, an ellipse, and a hexagon are all topologically identical in that they are all "loops," and any of these shapes can be obtained by deforming and stretching it). In topological data analysis (TDA), data points from large datasets are summarized into nodes, and the relationships between these nodes are connected by a line (also called an "edge"), thereby forming a large network of nodes connected by edges. This network has a particular "shape," and typical networks shapes are either "loops" (continuous circular segments) or "flares" (long linear segments) ( TDA can be combined with machine learning, which involves computer algorithms that adjust and learn from input data. These algorithms can automatically divide a large dataset into clusters of smaller datasets such that those within the same cluster group are more similar to one another than to those in other clusters (e.g., echocardiograms from normal subjects vs. those of patients with heart failure) (2). In unsupervised machine learning, no a priori knowledge of the expected outcome is incorporated, and the computer algorithm uses only the content of the input data to discover any possible underlying structure. Such combined machine learning and TDA techniques can be used to identify novel classifications systems or offer further insights into the natural history of diseases. In the first ever application of TDA in cardiovascular research, LGE (14) . The criterion to diagnose myocarditis was the presence of definite midwall and/or subepicardial

LGE in the absence of subendocardial LGE (15) . The Values are n (%) or median (interquartile range).

HR ¼ high-resolution; other abbreviations as in Tables 1 and 2 . Table 6 . Table 7 .

The present study is the first to introduce the use of Abbreviations as in Tables 1 to 3 . LGE (E,F) imaging were considered negative. HR LGE showed focal subendocardial enhancement on the inferolatero mid segment, consistent with microinfarction (arrows in G and H). Additional diagnostic work-up revealed no overt embolic cause on 24-h Holter monitoring, no biological substrate for thrombophilia, and no evidence of systemic vasculitis. Abbreviations as in Figure 1 . LGE showed myocardial infarction in the right ventricular outflow tract area, with microvascular obstruction (arrows in F and G). Given the presence of nonobstructive CAD, a mechanism of plaque disruption with spontaneous thrombus resorption was suspected. Abbreviations as in Figure 1 .

Lintingre et al. LGE extent (number of segments)

Values are mean AE SD, %, or median (interquartile range). *Statistical significance between negative CMR results and myocarditis. †Statistical significance between myocarditis and myocardial infarction. ‡Statistical significance between negative CMR results and takotsubo cardiomyopathy. §Statistical significance between myocarditis and takotsubo cardiomyopathy. kStatistical significance between myocardial infarction and takotsubo cardiomyopathy. ¶Statistical significance between negative CMR results and myocardial infarction. #Data not available in 16 (30%), 21 (30%), 17 (22%), and 1 (5%) patient, respectively. **Data not available in 14 (26%), 28 (39%), 25 (32%), and 7 (32%) patients, respectively. Tables 1 to 3 .

Lintingre et al. 

Values are median (interquartile range) or n (%). *Statistical significance between negative CMR results and myocarditis. †Statistical significance between myocarditis and myocardial infarction. BACKGROUND The diagnostic yield of catheterization among patients with suspected coronary artery disease (CAD) is low. Improved patient selection and diagnostic testing are necessary. The CAC score can minimize unnecessary diagnostic testing, and in low-risk patients, normal CMR results have a high negative predictive value. Less comprehensive protocols may be sufficient to guide further work-up.

METHODS A total of 642 consecutive patients (mean age: 63 years; 50% women) with stable chest pain and CAC scores of >0 who were referred for CMR were enrolled. Patients with a perfusion defect were subsequently examined by CAG.

Patients were followed up for 1 year. Outcome was obstructive CAD.

Obstructive CAD was present in 12% of patients. For CAD diagnosis, the sensitivity of adenosine CMR was 90.9% (95% confidence interval [CI]: 88.7 to 93.1), specificity was 98.7% (95% CI: 97.9 to 99.6), positive predictive value was 92.0% (95% CI: 89.8 to 94.1), and negative predictive value was 98.6% (95% CI: 97.6 to 99.5). A CAC score between 0.1 and 100 without typical angina was associated with obstructive CAD in only 3% of patients. Patients with nonanginal chest pain and a CAC score $400 had obstructive CAD (16%).

CONCLUSIONS Stress-only adenosine CMR had high diagnostic accuracy and served as an efficient gatekeeper to CAG in stable patients with a CAC score >0. Patients with CAC scores between 0.1 and 100 could be deferred from further testing in the absence of clinical features that suggested high risk. However, in patients with CAC score $400, functional testing should be indicated, regardless of the type of chest pain. (J Am Coll Cardiol Img 2020;13:1152-60) © 2020 by the American College of Cardiology Foundation.

C onventional coronary angiography (CAG) remains the reference standard for the diagnosis of obstructive coronary artery disease (CAD) (1,2). However, the diagnostic yield of catheterization among stable patients with suspected CAD is low, even after previous noninvasive testing (3, 4) . The accuracy of functional testing declines as the prevalence of obstructive CAD in men and women referred for evaluation of their chest pain falls (5) .

Consequently, positive test results are more likely to be false positive results. Therefore, improved patient selection and diagnostic testing are both necessary to efficiently identify patients with obstructive disease who might benefit from such testing.

The coronary artery calcium (CAC) score is an inexpensive and low radiation (<1 mSv) test that is suitable to minimize unnecessary diagnostic testing (6) . Absence of CAC in stable symptomatic individuals can identify subjects at low risk of cardiovascular disease and events. Among symptomatic patients, 20% to 50% were found to have a CAC score of zero (7, 8) . Further downstream testing in such patients has limited value (9, 10) . Although the frequency of ischemia increases with higher CAC scores, the CAC score itself does not differentiate obstructive disease from nonobstructive disease (11) Adenosine stress cardiac magnetic resonance (CMR) imaging is a popular noninvasive test for the detection of symptomatic obstructive CAD. It is attractive because of its lack of ionizing radiation and high spatial resolution (12, 13) . CMR accurately assesses myocardial perfusion. Stress myocardial perfusion imaging with CMR is more accurate in ruling out hemodynamically significant CAD than a single-photon emission computed tomography nuclear imaging test and exercise echocardiography (14) . In low-risk patients, as in patients without previous myocardial infarction, normal CMR results have a high negative predictive value (1, 2) , and less comprehensive protocols may be sufficient to guide further work-up and therapy (15, 16) .

The aim of this study was to assess whether, in patients with stable chest pain, adenosine stress-only perfusion CMR, in addition to a positive CAC score, could serve as an effective gatekeeper before CAG testing and could improve the diagnostic yield of CAG. Our second aim was to investigate the association between positive CAC scores and stress-induced myocardial ischemia. Siemens, Munich, Germany) was used to acquire a volume set of data of the heart according to a standard spiral protocol. Scans were made during maximal inspiration. CAC was measured by the Agatston method using dedicated software (20) . We 

A total of 642 patients met the inclusion criteria and constituted our study population. Their mean age was 63 years, and 50% were women ( Values are n (%).

CMR ¼ cardiac magnetic resonance; other abbreviations as in Table 2 .

Rijlaarsdam-Hermsen et al. that low CAC scores generally defined patients at low risk for manifesting inducible myocardial ischemia (11) . Furthermore, the CAC score provides additional prognostic information. A CAC score of zero safely ruled out obstructive CAD in many stable symptomatic patients (8, 9, 29 Our study indicated that patients with atypical symptoms and a low CAC score constituted a Table 2 . and European Society guidelines and is often used to determine who gets referred for invasive coronary angiography (2, 3) . In stable patients, coronary artery calcium (CAC) score has been shown to have prognostic value. Patients with a CAC score of 0 have low event rates, and the cardiac event rate increases with an increasing CAC score (4, 5) . Cardiovascular magnetic resonance (CMR) using stress perfusion has been shown to be highly accurate for the detection of significant CAD, and a normal CMR result confers a good prognosis (6, 7) . However, with a lower pre-test probability, the likelihood of false positives increases.

In standard clinical practice, perfusion CMR includes vasodilator stress and rest perfusion (8) . Reasons for rest perfusion include the ability to compare with stress perfusion in order to differentiate a true perfusion defect from the "dark rim" artifact (DRA) and to determine whether the perfusion defect is reversible (i.e., present at stress but not at rest) or fixed and matched (present at stress and rest), indicating an area of infarction. Additionally, the "splenic switch-off" sign, in which the spleen darkens with adequate stress and which suggests stress adequacy (9) , can be seen. Whether these features are truly advantageous in the real world is debatable. The cause of DRA is multifactorial and likely down to a combination of Gibbs ringing artifact and cardiac motion (10, 11) . It is, thus, affected by heart rate and cardiac function, which often differ with the differing hemodynamic states at stress and rest. Also, there are other ways to differentiate DRA from a true perfusion defect, including the persistence of the defect and the intensity of it relative to that of pre-contrast images.

With CMR, cine imaging and late gadolinium enhancement (LGE) are more reliable indicators of infarction, so the need to appreciate a reversible defect based on perfusion imaging is largely redundant. Finally, splenic switch-off can be seen on stress imaging alone and does not necessarily need a rest comparator. Stress-only CMR has previously been shown to be accurate in diagnosing CAD when read by experienced, level 3-accredited operators (12) .

In this issue of iJACC, Rijlaarsdam-Hermsen et al. (13) enrolled 642 consecutive patients who did not previously have myocardial infarction or undergo percutaneous coronary intervention but were suspected of having CAD and a CAC score of >0 for stress-only CMR results. The CMR results determined whether they underwent invasive coronary angiography (13). Patients were followed for 1 year, and obstructive CAD was defined as $50% stenosis in a vessel by invasive coronary angiography or a major adverse cardiovascular event(s) (MACE) within 12 months of CMR (13) . That study found obstructive CAD in 6% of patients with a CAC score of 0.1 to 100;

13% with a CAC score of 100 to 400; and 27% with a CAC score of $400 (13). A perfusion defect was detected in 87 patients (14%), and obstructive CAD was found in 77 of those patients (92%) (13) . Eight patients with normal stress CMR results had a MACE during the follow-up period (13) . That study found stress-only CMR results to be accurate with a sensitivity of 90.9%, a specificity of 98.7%, a positive predictive value of 92%, and negative predictive value of 98.6% (13) . The addition of stress-only CMR findings to a model including clinical variables and CAC scores increased the c-index from 0.82 to 0.97.

There are limitations to the study, and they were acknowledged by the authors. First, only patients with a positive perfusion CMR underwent invasive angiography, a lead bias which potentially underestimates the number of false negatives. Additionally, the gold standard of angiographic stenosis of a coronary vessel of $50% has limitations, and no measurement of invasive physiology was made.

Despite a highly selected cohort, only 14% of patients had a perfusion defect on CMR findings. Also, LGE imaging was not performed, and that may be useful in detecting pathology and giving prognostic information in high-risk patients. Finally, a follow-up period >1 year would be desirable to increase confidence in the results.

Barriers to accessing CMR, particularly in developing countries, include the cost and availability of scans, and this is directly related to the time per scan.

Other studies have shown the feasibility of 15-min CMR studies to improve accessibility and reduce cost (14) . The authors of this current work can be commended for demonstrating that a 15-min stressonly scan is also feasible, which further breaks down barriers to access CMR (13) .

Overall, the study adds to the growing evidence that stress-only CMR is sufficient in clinical practice.

With advances in CMR including improved spatial resolution with k-t sequences (15) METHODS STUDY POPULATION. The study population consisted of a randomly selected convenience sample aggregation of 2 international, multicenter, prospective observational registries that were described in detail elsewhere (6, 7) . Briefly, patients who underwent clinically indicated CCTA were included, with prospectively collected history, risk factors, and symptoms at baseline. Inclusion criteria were patients undergoing clinically indicated CCTA and age 18 years or older. Exclusion criteria were known coronary artery disease, hemodynamic instability, inability to provide consent, pregnancy, known adult congenital heart disease, baseline irregular heart rhythm, heart rate $100 beats/min, systolic blood pressure #90 mm Hg, contraindications to betablockers or nitroglycerin or adenosine, and uninterpretable CCTA. Each site obtained local institutional review board or ethics board approval.

IMAGE ACQUISITION AND SEGMENTATION. Scans were performed using $64 detector row scanners. Image acquisition, image post-processing, and data interpretation were performed according to current guidelines (8, 9) . Images were obtained and recon- Colored arrows indicate separate operations as shown. On a pixel level, this model was able to identify cardiac structures with high accuracy, as reflected by high Dice scores. Although a previous study using CCTA had a Dice score of 0.92, it used a thresholding, rather than a deep-learning method, to segment the LAA (15). A deep-learning method to segment the same structure obtained a superior Dice score of 0.95, as did one that segmented the LVM, with a score of 0.91 (16, 17) . However, in contradistinction to these studies, the present study identified multiple struc- In previous non-deepÀlearning studies, correlation coefficients were lower, not only between modalities, but between differing measurement methods within the same modality (26) . Furthermore, the agreement between the present prediction model and the ground truth was comparable to inter-and intra-reader agreements in multiple other manual studies (3,27).

A deep-learning model reproduced the same result Values are median (25th to 75th quartiles).

Abbreviations as in Table 2 .

Baskaran et al. In addition, the rapid 13s throughput could allow future integration into clinical workflows with minimal disruption, helping to reduce workload burden for the imaging clinician and minimizing fatigue (28) .

As such, this model tentatively portends clinical integration that increases interpretive speed at potentially low cost, while reducing sources of interpretive error.

STUDY LIMITATIONS. A limitation of this study was the cohort size. Although the study design included a hold-out 10% test set that was never seen until the final evaluation, this test set only included 17 patients. This hold-out set consisted of 1,477 images, which was more than amply acceptable for medical image-based, deep-learning applications (29) . The high Dice score attested to the model's robustness between these 2 groups, but overfitting could not be ruled out. Nevertheless, the model did make incorrect predictions ( Figure 3) . Furthermore, LVV wall prediction was significantly better in the younger than 65 years age group. Because the training, validation, and test sets were not significantly different, the difference in Dice score might perhaps be attributable to a higher prevalence of comorbidities that might have affected image quality (e.g., atrial fibrillation, respiratory disorders). This was outside the scope of the present study. A larger training and testing cohort and external validation will address these issues and improve real-world model performance. Integration of additional structures into the model (e.g., valves) will increase the applicability of the model. In addition, the scan timing of these images did not optimize contrast opacification of the RVV and RAV. Last, for image extraction and ease of integration into model architecture, annotation was done using Photoshop, instead of clinically conventional image annotation software, a gap that needs to be bridged for clinical integration. planes, which is known as the 2.5D approach (see for instance Mortazi et al. [5] for an application for cardiac structure segmentation); or 3) use a fully 3D network that takes volumetric input (e.g., 3D U-Net) (6) . Accommodating this requires either chopping the data up into parts or reducing resolution, even on state-of-the-art GPUs. Methods 2 and 3 (partially) conserve 3D consistency, whereas method 1 does not.

Generally speaking, methods 2 and 3 lead to higher performance (at least, when evaluated patient-wise and not slice-wise).

On the data side, there is a high demand for medical datasets with high-quality annotations (7, 8) . Part As the research field of AI matures, the times will come for clinicians and AI specialists to join forces and take AI applications from the catacombs of research to clinical day-to-day practice. To reach this (3). Studies demonstrated the CAC score significantly improved risk prediction above and beyond conventional RFs (7) (8) (9) (10) (11) . Absence of CAC is associated with an extremely low event rate despite having a high RF burden, thereby re-classifying these individuals as low risk for ASCVD (11, 12) . This ability of absence of CAC has been described as "power of zero." In addition, the presence and severity of CAC has been shown to strongly predict adverse outcomes, including all-cause mortality during 5 to 10 years of follow-up. However, whether CAC has differential association with subspecific mortality causes beyond 10 years of follow-up has not been studied.

Therefore, we aimed to examine the association of CAC with cause-specific mortality across baseline risk and to identify the prognostic value of high CAC among individuals without RFs and a CAC score of zero among high-risk individuals using data from the CAC Consortium. Values are mean AE SD or n.

CAC ¼ coronary artery calcium; CHD ¼ coronary heart disease. The participants were more likely to have higher coronary artery calcium (CAC) scores as the risk factor (RF) burden increased (p < 0.001).

Grandhi et al. RFs compared with those with 0 RFs ( Table 2) .

The HRs for all-cause mortality were increased Although the HRs for non-CVD mortality increased (1.18-to 2.00-fold higher) with increasing CAC, these HRs were lower than that of all-cause and causespecific mortality ( Table 2) . Figure 2 and Supplemental Table 1 show the annualized mortality rate with increasing CAC scores according to RF burden. Participants with CAC of 0 but without RFs had the lowest all-cause and cause-specific mortality rates, whereas participants with CAC $400 and $3 RFs had the highest all-cause and cause-specific mortality rates. Participants Table 1 . A greater increase in all-cause and cause-specific mortality was seen with increasing CAC scores within each RF group compared with worsening RF burden within each CAC group. CHD ¼ coronary heart disease; CVD ¼ cardiovascular disease; other abbreviations as in Figure 1 .

Grandhi et al. Our study was the first to document the association of CAC with CVD and CHD mortality, which might be considered more relevant outcomes to assess risk prediction compared with all-cause mortality. Across RF burden, 40% and 24% of deaths were due to CVD and CHD causes, respectively, among participants with CAC of $400, whereas 80% of deaths among those with CAC of 0 were attributable to non-CVD causes. Stronger association of CAC with CVD and/or CHD mortality, compared with all-cause mortality, challenges the exclusive use of traditional RFs for cardiovascular risk assessment to determine the intensity of primary prevention strategies.

The absence of CAC conferred low risk for CVD events and all-cause mortality across the range of RF burden, which was shown in a meta-analysis and in large prospective studies during 5 years of follow-up (12, 18, 19) . Blaha et al. (20) showed that nearly one- Abbreviations as in Tables 1 and 2 . Grandhi et al. Grandhi et al. 

Reprinted with permission from Lloyd-Jones et al. (6) . CAC ¼ coronary artery calcium. Because it is evident that CAC will not gain population-based screening approval without randomized trials, it is appropriate to narrow its application to treating individual patients, which, after all, is the essence of the practice of medicine. Naturally, radiation exposure, scan costs, and incidentalomas are potential concerns, as well as denying the option of CAC to those who cannot afford the test. These same objections have been considered and dismissed for the 5% to <20% 10-year risk group who are already included in the guideline. Insurance coverage for this increasingly inexpensive test would be extremely helpful but is still, for the most part, unavailable.

In this era of patient-centered imaging and shared decision making, it is unacceptable for the public, and Table 1) were grouped together as having a clinician- and centrifugal (n ¼ 12) continuous-flow pumps.

Baseline data for the groups with (n ¼ 11) and without (n ¼ 8) LVAD infections are shown in Table 1 . A statistically significant difference was noted with respect to age (p ¼ 0.013). No differences were noted between the remaining demographic and history characteristics. Importantly, no between group differences were noted in traditional infectious markers Patient-level clinical data for the nineteen scans were collected (Supplemental Table 2 ). Compared Table 3 ) showed overall low risk for bias for patient selection, unclear risk for bias for index test and flow or timing, and high risk of bias for reference standard. The high risk for bias with the reference standard domain is due to lack of a true gold standard test for diagnosing LVAD infections. There is overall low concern for applicability in all domains.

Study characteristics and outcomes. Included publications are summarized in Table 2 Figure 5 shows the forest plots of individual study sensitivity and specificity. Pooled sensitivity was 92% (95% CI: 82% to 97%) and speci- Tam et al. likelihood of heterogeneity (32, 33) . For the studies included in the meta-analysis, heterogeneity was low with respect to sensitivity (I 2 ¼ 0.00%), but given the wide CI, the significance is unclear. With respect to specificity (I 2 ¼ 80.71%), heterogeneity was high.

Although this may reflect random chance, methodology errors, or study design differences, there is likely a component of a threshold effect. Sensitivity and specificity are linked variables that change inversely based on the threshold for relative FDG uptake. Currently no universally accepted standard has been set, which may limit the current utility of this testing. The limited number of studies also leads to an underpowered analysis. Suspected LVAD infections can be difficult to diagnose and often require integrating clinical and testing data (3, 4) . As noted in this case series, traditional blood biomarkers of infection ( Table 1 ) and

imaging with TEE and CT (Supplemental Table 2 Go to http://www.acc.org/ jacc-journals-cme to take the CME/MOC/ECME quiz for this article. Recognizing this heterogeneity, the International Society for Heart and Lung Transplantation developed a classification system to catalogue infection into device-specific, device-related, or nondevice infection (7) . The diagnostic journey to define and classify these infections requires a structured approach to initially include system-level diagnosis (infection biomarkers, blood and urine cultures, and radiography), and then attention shifts to a more device specific diagnosis to look "near" and Following treatment of culprit vessels, patients began medical therapy according to local guidelines. There were no significant differences between the 2 groups for antiplatelet, statin, angiotensin-converting enzyme inhibitor, or beta-blocker therapy, either at discharge or follow-up (Supplemental Table 2 ). Table 3 ). Gray-scale IVUS analysis revealed some differences between the 2 groups. Figure 3D ). PSS and variations in PSS were also increased in the MACE group when VH-TCFAs with an MLA #4 mm 2 specifically was examined ( Figure 3E) but not VH-TCFA with PB $70% ( Figure 3F) . 

Both post-mortem and prospective VH-IVUS studies have identified TCFA (or VH-TCFA) as the lesion most likely to rupture (2, 4, 5, 11 Figures 1 and 3 . Evidence from experimental models of acute infarction showed substantial correlation between unenhanced dual-source CT and T2-weighted CMR to detect myocardial edema (29) . The area presenting with edema in unenhanced CT, but without delayed enhancement in the late phase, is likely to correspond to the salvageable area at risk.

The use of MDCT to detect diffuse abnormalities of myocardial tissue is significantly more challenging than the evaluation of regional scar, due to the low contrast resolution. A small study in patients with heart failure and healthy individuals found a good LGE images may be used to highlight areas of focal fibrosis compared with normal myocardium.

Myocardial fibrosis causes significant expansion of the extracellular space, leading to a higher regional concentration of GBCAs and an area of relative hyperenhanced signal (34 (37) and may be more sensitive for directly quantifying the area at risk (35) . Microvascular obstruction may be seen on resting first-pass perfusion, early gadolinium enhancement, or LGE images, with good correlation to histopathology, and confers a poor prognosis (38) . Intramyocardial (44) . In contrast, because T1 mapping and ECV might detect both acute and chronic changes, some reports suggest that T2 mapping might be more specific to acute myocardial edema and inflammation (48, 49) .

Myocardial fibrosis detection using LGE.

LGE is still considered the clinical gold standard for identifying areas of myocardial infarction with high spatial resolution, including small subendocardial scars that may be missed by SPECT (50) . Multiple studies have demonstrated excellent spatial correlation between areas of myocardial scarring identified on LGE imaging and histopathology, both in the acute and chronic phases of infarction (51) . The transmural extent of infarction on LGE inversely predicts the likelihood of regional contractile recovery after revascularization (52) and is the current CMR standard for myocardial viability assessment.

LGE in a predominantly nonischemic (non-subendocardial) pattern is also present in a significant proportion of patients with nonischemic myocardial injury and cardiomyopathies (10) . Its presence is strongly associated with poor prognosis, including increased risk of all-cause mortality, heart failure hospitalization, and sudden cardiac death (53) .

Depending on the LGE pattern and distribution, CMR may, together with functional and morphological imaging, be used to diagnose specific cardiomyopathies (detailed review elsewhere [10] ). Areas with

LGE in nonischemic cardiomyopathies often correlate to (although are not specific for) areas of focal fibrosis on histopathology. For instance, the areas of mid-wall and subepicardial LGE typically seen in myocarditis ( Figure 5 ) correlate to areas of inflammation, myocyte necrosis, and fibrosis (54). In dilated cardiomyopathy, mid-wall enhancement often seen in the interventricular septum (and LGE imaging showed multiple areas of mid-wall, subepicardial, and patchy enhancement in a noncoronary distribution. (D) Native T1 mapping using the ShMOLLI Aortic stenosis is a condition characterized by a number of pathophysiological changes in the heart as the disease progresses, including LV hypertrophy, 

Tissue composition changes such as fibrosis, edema, or infiltration are frequent features in myocardial diseases.

Cardiac imaging modalities offer the ability to characterize myocardial tissue to varying extent.

Cardiovascular magnetic resonance offers comprehensive myocardial tissue characterization by providing various diagnostic and prognostic imaging biomarkers.

Advanced cardiac imaging is expected to become an integral part in risk stratification and personalized medicine. 

The theory and underlying methods behind diffusion MR were developed in the 1960s by Stejskal and Tanner (9) and advanced in the 1990s (10). The first clinical application of diffusion imaging was in neurology, where it was used for the early diagnosis of stroke (11) . Cardiac diffusion imaging is considerably more difficult due to the bulk motion of the heart, but Edelman et al. (12) were able to overcome this by using a stimulated echo acquisition mode The key limitation of basic SE is cardiac motion that occurs during diffusion weighting, which is approximately 3 orders of magnitude greater than the distances diffused by water molecules and leads to large artefactual signal dropout. This was first addressed by bipolar diffusion gradients that offered first-order motion (constant velocity) compensation (20) . Second-and third-(acceleration and jerk) order motion compensation techniques were then developed, although these require high performance gradient systems ( Figure 6A ) (14, 21, 22) . Third-order motion compensation addresses the more complex diastolic motion, but requires longer echo times, so second-order motion compensation (M2-SE) is considered optimal. Thus, M2-SE data are typically acquired in systole (23, 24) . Validation using in vivo and post-mortem M2-SE DT-CMR in pigs has shown good levels of agreement (25) . An M2-SE approach is Fig . 6 . Fig . 7 . Fig . 8 . Fig . 2 . Fig . 3 . Fig . 4 .

attractive and growing in popularity because of the higher signal-to-noise ratio than alternative methods, its suitability for free-breathing acquisition, and its more efficient whole heart coverage. It has been used in several initial human studies (14, 22, 26, 27) . A variation on M2-SE is a diffusion prepared method that allows a flexible choice of image acquisition (22) .

A leading alternative sequence type is STEAM, and this addresses bulk motion artefact by splitting the 180 pulse into 2 90 pulses, so that the time over which diffusion is measured (D) is an RR interval, and each image is acquired over 2 cardiac cycles ( Figure 6B ). Data acquisition is synchronized so that the heart is in the same position when both diffusion gradients are applied, thus minimizing the effects of cardiac motion. STEAM has been the mainstay of recent clinical DT-CMR studies because it does not require specialist hardware or motion compensation.

Since its initial success in producing diffusionweighted CMR images, STEAM has been readily applied to DT-CMR in both healthy and diseased hearts (8, 12, (28) (29) (30) . However, the wide applicability of STEAM is offset by several disadvantages. It has low signal-to-noise ratio, requires 2 regular breath-holding or a navigator-led approach, and excludes patients with arrhythmias (31) . Another disadvantage of STEAM in measuring diffusion is the effect of strain.

Strain, a measure of myocardial deformation, has been proposed as a confounder of DT-CMR results (28, 32) . (8, 36) . Consequently, the dynamic, laminar, and semi-permeable nature of the myocardium means strain has a complex, but limited effect on measured diffusion and requires further study (29, 36, 37) . with the predominant sheetlet orientation, and E3

with the sheetlet normal direction (Supplemental Table 1 ) (5, 8, (38) (39) (40) (41) (42) (43) . Helix angle. The primary eigenvector, the long axis of the diffusion ellipsoid, is projected onto the into the circumferential-radial plane and then calculating the angle with the circumferential direction (38, 43) .

Secondary eigenvector angulation. The secondary eigenvector is projected onto the cross-myocyte plane ( Figure 9 ). The angulation between E2 projected into this plane and the myocyte perpendicular direction is termed E2A and is an index of sheetlet orientation (8) . Unlike E1A, E2A orientation changes substantially between systole and diastole. This change is called E2A mobility and reflects sheetlet function (8) .

Tertiary eigenvector angulation. The tertiary eigenvector angulation (E3A) is perpendicular to the sheetlet plane. E3 is projected onto the longitudinalradial plane and is positive when directed apicobasally (upward).

Mean diffusivity. In DT-CMR, mean diffusivity (MD) is derived from the tensor (19) . It is the mean of l 1, l 2 , and l 3 and measured in units of square millimeters per second. MD reflects the packing and integrity of the myocytes, with low values indicating tight packing. MD rises with interstitial abnormality (e.g., fibrosis) because water has more freedom to diffuse (26, 44) . MD is similar to the mean ADC from diffusion-weighted CMR.

Fractional anisotropy. Fractional anisotropy (FA) is a scalar value reflecting the degree, but not direction, of anisotropy. Isotropic diffusion has an FA value of 0, and diffusion restricted to a single direction has a value of 1 ( Figure 10) . FA reflects the degree of 

Clinical applications of DT-CMR are in relative infancy, but the unique ability to provide in vivo (24, 47, 48) . In vivo human studies comparing M2-SE and STEAM report higher MD and lower FA using M2-SE (24, 27) . This result is expected because with a shorter diffusion time, water molecules encounter fewer restrictive barriers ( Figure 11 ). Reported values for MD and FA are provided in Supplemental Table 2 . MD and FA tend to be provided as global values, usually across a mid-ventricular slice. However, regional differences have been Table 1 ) and report only minor changes in cardiomyocyte orientation toward a more longitudinal systolic orientation, as shown in Figure 12 (8, 35, 50) . The transverse angle lies in the region of À20 to þ20 , at both cardiac phases (43). SHEETLET ORIENTATION. E2A is used as a DT-CMR index of sheetlet orientation, although E3 is used by some investigators. E2A changes substantially through the cardiac cycle (8) . Figure 13 shows how sheetlets adopt a wall parallel sheetlet orientation in diastole (blue), which becomes more wall perpendicular in systole (red). This reorientation is intimately linked to the generation of radial strain.

A small movement in the longitudinal direction translates into a larger radial expansion, similar to the perpendicular amplification action of a "lazy tong" (Supplemental Ref. 1 ). This is demonstrated by glyphs in Figure 13 and shown in Video 1.

Biphasic differences in E2A have been described; a STEAM study of healthy humans reported diastolic 

Fractional anisotropy (FA) in the heart reflects the underlying myocyte organization, such that a value towards zero reflects little organization and a value nearer 1 reflects a more organized structure (packed and anisotropic). Reproduced with permission from Scott et al (24) . Abbreviations as in Figure 6 .

although only the latter was significant (59) . Although this might be related to septal hypertrophy and expanded extracellular space due to fibrosis and disarray, technical factors such as spatial variation in the signal-to-noise ratio might also be responsible; histological validation was absent. A preliminary study suggested FA was focally reduced in patients with HCM compared with control subjects and that DT-CMR might be able to detect myocardial disarray (60) . Figures 17A and 17C) showed predominance of low diastolic E2A and a broader systolic distribution. Figures 17B and 17D) . (16 ) , yielding a reduced E2A mobility and impaired sheetlet mobility ( Figure 18 ). Both radial and circumferential strains were significantly and similarly reduced in the cardiomyopathy groups compared with control subjects. However, the range of E2A (low to low in DCM and high to high in HCM) provided mechanistic insight into these findings. This study was limited by the mean ejection in those with recovered DCM was 59 (14 ) , which was significantly greater than the DCM group (35 [17 ] ;

p < 0.0001), but lower than the control subjects (65 [8 ] ; p ¼ 0.01). When E2A mobility was plotted against the EF, patients with recovered DCM and control subjects were indistinguishable by EF but could be discriminated by E2A (Figure 19 ). Together, these 2 studies suggest that DT-CMR can detect impaired sheetlet behavior in dilated cardiomyopathy that appears to persist even when LV size and EF recover to normal by conventional measures. 

Example E2A maps of a mid-ventricle slice. The healthy control subject has a blue (low E2A) map in diastole and a red (higher E2A) map is systole. In hypertrophic cardiomyopathy (HCM), maps are predominantly red, displaying elevated E2A at both cardiac phases. The plot below shows that diastolic E2A is significantly elevated compared with the healthy control subjects, as is systolic E2A. Adapted with permission from Ferreira et al. (29) . Abbreviation as in Figure 13 .

Khalique et al. LV tractography of a situs solitus (SS) and situs inversus (SIT) heart. The contrast between the left-handed helix (blue) in the SS heart, and the right-handed helix (red) in the SIT heart is particularly striking. Modified with permission from Khalique et al. (62) . DT-CMR has identified novel cardiomyocyte and sheetlet abnormalities in cardiac disease in vivo.

DT-CMR has the potential to aid clinical diagnosis and risk stratification through microscopic phenotyping. have shown that the SoMe promotion strategy is associated with higher readership and downloads, although a 2015 randomized trial showed no effect (8, 9) . Correlation between the AAS score and citations have been modest but have also been stronger when assessing the early impact of clinical trials or meta-analyses (9, 10) . The "knowledge chunks" derived from were generally less downloaded ( Table 1) Table 2 ). The hashtag, specifically introduced by the octothorpe symbol (#), is a metadata tag that allows users to search for all posts tagged with that message.

Tracking the most relevant SoMe hashtags in imaging reveals tens of millions to hundreds of millions of estimated digital impressions from thousands of global participants online ( Table 2) . Hashtag topics of interest shared broadly should not be ignored. These include: 1) #ThePowerofZero, which is bringing attention to the role of zero CAC imaging for the prediction of cardiovascular events (15) (16) (17) (18) ; 2) #CardsRads, which discusses approaches to cardiology and radiology collaborations in advanced imaging (19) ; and 3) #Structural and #iEcho, which expand discussions around advocacy, clinical training, and reimbursement issues in this rapidly evolving field (20) (21) (22) . Here, we didactically present PET, CMR, and fused PET/CMR images highlighting the strengths of such combined morpho-functional investigation in 5 selected patients with cardiac malignancies and addressed for tumor aggressiveness evaluation (Figure 1 ), lesion topographic assessment (Figure 2 ), disease extension definition (Figures 3 and 4) , or treatment efficacy evaluation ( Figure 5 ). recognized on PET and CMR hybrid images. This case suggests that PET/MR with radiotracers specifically targeting neuroendocrine phenotype (i.e., 18 F-FDOPA, 68 Ga-DOTA-peptides) will increase the noninvasive detection of asymptomatic cardiac metastases in patients with NETs.

El Ghannudi et al. Figure 1B) . This finding held true in men and women, without sex differences. By Cox proportional hazards modeling, the addition of inducible ischemia to a model We studied patients with CS undergoing cardiac FDG-PET before and after corticosteroid therapy with prednisone. Our aim was to assess the effect of low timely diagnosis of CAR is crucial, especially because effective immunosuppressive therapies are available.

Repeated endomyocardial biopsy (EMB) is the gold standard for the diagnosis of CAR, but it requires radioscopy and is associated with 0.2% to 5.5% of serious complications (2, 3) . Therefore, we explored less invasive diagnostic strategies.

Dynamic computed tomography perfusion (CTP) is a novel noninvasive imaging method; however, its role in patients who have undergone OHT is unknown. Therefore, we aimed to determine the feasibility of dynamic CTP as a noninvasive imaging method for identification of CAR, as evaluated histologically.

Consecutive patients were recruited before third

week and the end of third month after OHT be- Early CAR clinical manifestations may present late, and routine EMB is not only an aggressive, but also sometimes false negative examination for rejection detection. There is still a need for improvement of noninvasive diagnostics following OHT. Dynamic CTP advantages include safety, simplicity, and the ability for qualitative and quantitative analyses, but disadvantages include radiation and contrast use. To the best of our knowledge, this was the first study that analyzed dynamic CTP in heart transplantation recipients. The study findings might be limited by small sample size and low eligibility due to the highly restrictive inclusion criteria aimed to protect patients in the pilot study. However, high statistical significance of the revealed relationships might reinforce our findings and suggest diagnostic robustness of the novel method.

In conclusion, the dynamic CTP is sensitive to early perfusion abnormalities in heart transplantation recipients with CAR and has the potential to serve as an alternative screening tool. Our pilot study resulted in findings that need confirmation in a larger patient population with wider eligibility criteria. Using STE, we obtained peak systolic strain, postsystolic strain, and maximal strain from 1 cardiac cycle ( Figure 1A) . Global longitudinal strain (GLS) denoted the maximal strain, and the mean postsystolic index (PSI) was defined as: [100 Â (post-systolic strain À peak systolic strain)]/maximal strain.

Measurements were averaged across 18 segments.

Stress testing for ischemic changes was not performed.

In time to first-event analyses, we applied Cox proportional hazards models to assess the association between mean PSI and endpoints. We applied a single multivariable model of age, sex, hypertension, smoking status, duration of diabetes, dyslipidemia, estimated glomerular filtration ratio, use of insulin, Using STE, we obtained peak systolic strain, postsystolic strain, and maximal strain from 1 cardiac cycle ( Figure 1A) . Global longitudinal strain (GLS) denoted the maximal strain, and the mean postsystolic index (PSI) was defined as: [100 Â (post-systolic strain À peak systolic strain)]/maximal strain.

Measurements were averaged across 18 segments.

Stress testing for ischemic changes was not performed.

In time to first-event analyses, we applied Cox proportional hazards models to assess the association between mean PSI and endpoints. We applied a single multivariable model of age, sex, hypertension, smoking status, duration of diabetes, dyslipidemia, estimated glomerular filtration ratio, use of insulin, We did not detect differences in focal or diffuse myocardial tissue composition between the groups. mapping sequences, each center should compare the proposed T1 cutoffs with its cohort of healthy normal subjects or identify its optimal cutoffs. Moreover, native T1 was measured in the basal to mid septum of the 4-chamber map, a method that on the 1 hand is straightforward and reliable, but on the other hand does not take into account the regional distribution of T1 values across all ventricular segments. Second, the positive and negative predictive values of these cutoffs are heavily influenced by disease prevalence in the population studied (2), which in this case (3) . In this study, post-preeclamptic women showed LA volume/BSA above this cutoff. LA enlargement is an integrative marker of pathophysiological processes, such as LV diastolic dysfunction, atrial fibrillation, and stroke (3, 4) . We did not detect differences in focal or diffuse myocardial tissue composition between the groups. incorporating multidimensional approaches to probability including additional imaging and clinical features. Deep learning approaches (ridge regression, random forest, etc.) will be needed to develop best possible ways of interpretation. In terms of diagnostic gold standard, we agree that the sensitivity of a periumbilical fat pad biopsy is only 73% (3). However, individual patients in this cohort had multiple biopsies with at least 1 positive biopsy in each individual case.

We fully agree with the issues surrounding the truth standard for disease and selection bias induced in cohorts based on the use of invasive or noninvasive imaging; all approaches have limits, and our work therefore serves as a standard that should be prospectively tested at other, ideally multicenter sites.

Finally, although only a relatively small proportion of patients had an estimated glomerular filtration rate <30 ml/min/1.73 m 2 , 45 patients with suspected cardiac amyloidosis and estimated glomerular filtration rate <30 ml/min/1.73 m 2 represents the biggest group with these characteristics ever published so far.

In conclusion, whilst we fully acknowledge that this study has certain limitations, it represents the largest study on the utility of native T1 mapping for the diagnosis of cardiac amyloidosis and as such, is an important step for the field. "B lack swan" events are by definition unexpected (even if the "black swan" has been visible before) and come with catastrophic consequences. One such occurrence is the current coronavirus pandemic, which is likely to have a considerable impact on the practice of medicine in as yet unknown ways. A likely consequence will be a significant economic downturn and constrained budgets, resulting in even higher pressure to optimize our diagnostic and therapeutic pathways.

To survive the cost pressure, diagnostic studies will have to evolve significantly: they must be fast, use the most cost effective approach, and result in a therapeutic consequences or management guidance.

Shorter examinations require focus on the core question, standardized image acquisition and procedures, and rapid, increasingly automized data analysis and reporting. Cost-effectiveness requires more research, but also using the knowledge we have to reduce unnecessary diagnostic and therapeutic procedures.

In this issue of iJACC, Rijlaarsdam-Hermsen et al.

(1) provide information on one strategy that seems and Care Excellence guidelines (9) and is based mainly on the notion that exclusion of CAD can be done with limited effort and costs using CT angiography. Advances in CT perfusion (10) could substantially buttress this argument. This approach is also supported by the high negative predictive value of CT angiography and data from the SCOT-HEART (Scottish Computed Tomography of the HEART Trial) trial (11) , demonstrating that knowledge of coronary anatomy and plaques improves outcomes. In contrast, this approach has the disadvantage that the majority of patients will have negative results on computed tomography, which requires nephrotoxic contrast agents, a rare, but not negligible prevalence of allergic reactions and some ionizing radiation, thus also adding significantly to the overall cost. CMR imaging allows a combination of function, scar imaging, mapping, and perfusion and can serve as an attractive "go to" test; it is well validated, allows precise quantitation and a high degree of automation (12) , and is one of the few tests that shows noninferiority compared with an invasive fractional flow reserve-based strategy for the management of stable CAD (13). However, it will have to overcome limited availability and the need for a high degree of expertise.

A Bayesian approach might continue to find favor despite evidence against it (9 abnormal results, has found some favor and is supported by at least 1 small randomized controlled trial (15) . A combination of CAC scoring and perfusion CMR is a variation that strategy and now has evidentiary support (1). This approach reduces the need for invasive angiography, while minimizing the need for perfusion scanning in those with low calcium burden, further shortening the CMR study and eliminating the need to apply vasodilator stress in a considerable group of patients. Using biomarkers alone for predicting CAD has been less than conclusive so far (16) , and a combination of imaging and biomarkers might improve performance. Hybrid imaging-using multiple modalities around the same time (either individually or on the same machine, as with positron emission tomography/computed tomography or positron emission tomography/magnetic resonance)-is attractive but may not adequately fulfill its promise at this time (17) .

Value-added testing, using CMR or CT angiography, might become one of the more attractive avenues for cost-effective imaging. Some strategies might provide important insights regarding anatomy, physiology (18) , blood flow quantitation, microvascular health (19) , and information about the vessel wall (20) and prognosis in the same test environment.

Both computed tomography and CMR allow this, and rapid advances, including automation (12, 21) and machine learning (22) , may allow novel paradigms.

For example, it would be interesting to investigate whether a CAC scan (without CT coronary angiography) and a noncontrast CMR study could be combined in a specific group of patients, obviating the need for contrast injection or even vascular access for a stressor administration (23) , which could considerably increase patient throughput and offer testing at a much lower cost than currently possible.

Whether such multimodality approaches can save costs needs to be determined.

We need to start focusing less on the diagnosis of 

Atherosclerotic risk factors revisited

Interplay of coronary artery calcium and risk factors for predicting CVD/CHD mortality: the CAC consortium

ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology

PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines

Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease

Eighth annual INTERMACS report: special focus on framing the impact of adverse events

International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary

Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis

The role of 18F-FDG PET/CT in infectious endocarditis: a systematic review and meta-analysis

Metaanalysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis

Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a metaanalysis

Molecular Imaging for the diagnosis of infective endocarditis: a systematic literature review and meta-analysis

Impact of F-18 FDG PET-CT for the diagnosis and management of infection in JARVIK 2000 device

The usefulness of FDG PET/CT imaging in suspicion of LVAD infection

FDG PET/ CT Imaging for LVAD Associated Infections

FDG-PET/CT for driveline infection in a patient with implantable left ventricular assist device

Contributory role of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis and clinical management of infections in patients supported with a continuous-flow left ventricular assist device

The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections

Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection

World Health Organization. Cardiovascular diseases (CVDs)

A prospective natural-history study of coronary atherosclerosis

Nonfibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study

Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study

In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the AtheroR-emoIVUS study

Sites of rupture in human atherosclerotic carotid plaques are associated with high structural stresses: an in vivo MRI-based 3D fluid-structure interaction study

Coronary plaque structural stress is associated with plaque composition and subtype and higher in acute coronary syndrome: the BEACON I (Biomechanical Evaluation of Atheromatous Coronary Arteries) study

Plaque rupture in coronary atherosclerosis is associated with increased plaque structural stress

Plaque structural stress estimations improve prediction of future major adverse cardiovascular events after intracoronary imaging

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study

Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study

Localized elevation of shear stress is related to coronary plaque rupture: a 3-dimensional intravascular ultrasound study with in-vivo color mapping of shear stress distribution

for the Committee FS Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease

for the PROSPECT Investigators. A prospective naturalhistory study of coronary atherosclerosis

Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VHIVUS in Vulnerable Atherosclerosis) study

In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the AtheroRemoIVUS study

Biomechanical stress profiling of coronary atherosclerosis. Identifying a multifactorial metric to evaluate plaque rupture risk

Relationship between local endothelial shear stress and nearinfrared spectroscopy lipid signal in patients with coronary artery disease: implications for plaque destabilization

Role of low endothelial shear stress and plaque characteristics in the prediction of nonculprit major adverse cardiac events: the PROSPECT study

Impact of longitudinal lesion geometry on location of plaque rupture and clinical presentations

Heterogeneity of plaque structural stress is increased in plaques leading to MACE: insights from the PROSPECT study

Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in-vivo IVUS study

Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in Mice. Implications for superficial erosion

Intraplaque haemorrhages as the trigger of plaque vulnerability

Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing betablocker therapy

Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

Myocardial edema: a translational view

Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function

Pathological hypertrophy and cardiac interstitium. Fibrosis and reninangiotensin-aldosterone system

Cardiac MRI: a central prognostic tool in myocardial fibrosis

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

The role of cardiovascular magnetic resonance imaging in heart failure

Left ventricular lipomatous metaplasia following myocardial infarction

Iron overload cardiomyopathy in clinical practice

Amyloid fibrils: abnormal protein assembly

In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans

Assessment of diastolic function using ultrasound elastography

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery

Assessment of nonischemic myocardial fibrosis

Highfrequency ultrasound for quantitative characterization of myocardial edema

SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability

Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction

Nonbiopsy diagnosis of cardiac transthyretin amyloidosis

Impact of scar on water-perfusable tissue index in chronic ischemic heart disease: evaluation with PET and contrast-enhanced MRI

Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study

PET imaging in heart failure: the role of new tracers

Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

Advances in imaging for diagnosis and management of cardiac sarcoidosis

Diagnostic accuracy of CT for the detection of left ventricular myocardial fibrosis in various myocardial diseases

Prognostic value of LGE-CMR in HCM: a meta-analysis

Myocardial scar and mortality in severe aortic stenosis

Assessment of myocardial fibrosis with T1 mapping MRI

Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction

Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents

Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction

Native T1 Mapping by 3-T CMR imaging for characterization of chronic myocardial infarctions

Extra-cellular expansion in the normal

Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine

Fiber orientation in the canine left ventricle during diastole and systole

Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog

Evaluation of left ventricular torsion by cardiovascular magnetic resonance

Assessment of myocardial microstructural dynamics by in vivo diffusion tensor cardiac magnetic resonance

Spin diffusion measurements: spin echoes in the presence of a timedependent field gradient

Imaging of diffusion and microcirculation with gradient sensitization: design, strategy, and significance

Fast magnetic resonance diffusionweighted imaging of acute human stroke

In vivo measurement of water diffusion in the human heart

Optimal diffusion weighting for in vivo cardiac diffusion tensor imaging

Second-order motioncompensated spin echo diffusion tensor imaging of the human heart

Squashing peanuts and smashing pumpkins?: How noise distorts diffusionweighted MR data

In vivo study of microcirculation in canine myocardium using the IVIM method

Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging

Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system

Estimation of the effective self-diffusion tensor from the NMR spin echo

Diffusion imaging of the in vivo heart using spin echoesconsiderations on bulk motion sensitivity

Quantifying precision in cardiac diffusion tensor imaging with second-order motion-compensated convex optimized diffusion encoding

In vivo diffusiontensor MRI of the human heart on a 3 tesla clinical scanner: an optimized second order (M2) motion compensated diffusion-preparation approach

In vivo diffusion tensor MRI of the human heart: reproducibility of breath-hold and navigator-based approaches

Measuring diffusion in the presence of material strain

Cardiac diffusion MRI without motion effects

Cardiac diffusion tensor MRI in vivo without strain correction

Dual-phase cardiac diffusion tensor imaging with strain correction

ex vivo porcine hearts

Probing dynamic myocardial microstructure with cardiac magnetic resonance diffusion tensor imaging

Histological validation of myocardial microstructure obtained from diffusion tensor cardiac magnetic resonance

Magnetic resonance myocardial fiber-orientation mapping with direct histological correlation

Direct histological validation of diffusion tensor MRI in formaldehyde-fixed myocardium

iJACC in the evolving world of integrated imaging: a spectator, a follower, or a trail blazer

Journal editors and altmetrics: moth to the flame?

JACC: Cardiovascular Imaging Editors. Progress in cardiovascular imaging

JACC: Cardiovascular Imaging Editors. Progress in cardiovascular imaging

Understanding social media: opportunities for cardiovascular medicine

Impact factor: a curious and capricious metric

Accelerating the future of cardiac CT: social media as sine qua non?

A randomized trial of social media from Circulation

Effect of promotion via social media on access of articles in an academic medical journal: a randomized controlled trial

Correlation of Altmetric Attention Score with article citations in cardiovascular research

Association between recreational cannabis use and cardiac structure and function

Academic cardiology and social media: navigating the wisdom and madness of the crowd

Coronary CT angiography and 5-year risk of myocardial infarction

CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an openlabel, parallel-group, multicentre trial

Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke: the Walter Reed Cohort Study

Message for 2018 cholesterol management guidelines update: time to accept the power of zero

Building bridges in cardiology and radiology: why collaboration is the future of cardiovascular imaging

Navigating a career in structural heart disease interventional imaging

Core competencies in cardiac CT for imaging structural heart disease interventions: an expert consensus statement

Gong FF, Campbell DJ, Prior DL. Noninvasive cardiac imaging and the prediction of heart failure progression in preclinical stage A/B subjects

Epidemiology of left ventricular systolic dysfunction and heart failure in the Framingham Study: an echocardiographic study over 3 decades

2-and 3-dimensional myocardial strain in cardiac health and disease

Potential usefulness and clinical relevance of adding left atrial strain to left atrial volume index in the detection of left ventricular diastolic dysfunction

LA strain for categorization of LV diastolic dysfunction

Relationship between left ventricular ejection fraction and mortality in asymptomatic and minimally symptomatic patients with severe aortic stenosis

Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta-analysis

Doppler echocardiography for the estimation of LV filling pressure in patients with mitral annular calcification

Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions

Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials

Mor-Avi V. 3-dimensional echocardiography: latest developments and future directions

Functional implication of mitral annular disjunction in mitral valve prolapse: a quantitative dynamic 3D echocardiographic study

Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis

Analytical quantification of aortic valve 18F-sodium fluoride PET uptake

Randomized comparison of clinical effectiveness of pharmacologic SPECT and PET MPI in symptomatic CAD patients

Using radiation safely in cardiology: what imagers need to know

Available at: https:// soundcloud.com/bmjpodcasts/radiation-what-weneed-to-know

Reduction of SPECT MPI radiation dose using contemporary protocols and technology

Promoting appropriate use of cardiac imaging: no longer an academic exercise

Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial

Effects of statins on coronary atherosclerotic plaques: the PARADIGM study

Selective referral using CCTA versus direct referral for individuals referred to invasive coronary angiography for suspected CAD: a randomized, controlled, open-label trial

Coronary artery calcification and its progression: what does it really mean?

Coronary artery calcification: from mechanism to molecular imaging

Long-term all-cause and cause-specific mortality in asymptomatic patients with CAC $1,000: results from the CAC Consortium

Family history of CHD is associated with severe CAC in South Asians: comparing the MASALA and MESA studies

Coronary artery calcium and cardiovascular events in patients with familial hypercholesterolemia receiving standard lipid-lowering therapy

Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement

Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy

Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy

Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis

LV Noncompaction cardiomyopathy or just a lot of trabeculations?

Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries

Assessment of subclinical left ventricular dysfunction in aortic stenosis

Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement

Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis

Imaging and impact of myocardial fibrosis in aortic stenosis

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States

Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA

Contemporary impacts of a cancer diagnosis on survival following in-hospital cardiac arrest

Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY Trial

Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient

Chemotherapeutic agents and the risk of ischemia and arterial thrombosis

Cardiovascular magnetic resonance in the oncology patient

Intraprocedural imaging of transcatheter tricuspid valve interventions

Transcatheter interventions for mitral regurgitation: multimodality imaging for patient selection and procedural guidance

Imaging for mitral interventions: methods and efficacy

Imaging for predicting and assessing prosthesis-patient mismatch after aortic valve replacement

Roles of transesophageal echocardiography and cardiac computed tomography for evaluation of left atrial thrombus and associated pathology: a review and critical analysis

Cardiac 3D printing and its future directions

Quantitative prediction of paravalvular leak in transcatheter aortic valve replacement based on tissuemimicking 3D printing

Global burden of atherosclerotic cardiovascular disease in people living with HIV

Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients

HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema

Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus

Global burden of atherosclerotic cardiovascular disease in people living with HIV

Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients

HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema

Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus

MD* *Division of Cardiology Johns Hopkins Hospital 600 North Wolfe Street Baltimore, Maryland 21287 E-mail: naggarw2@jhmi

FIGURE 1 Representative Pre-and Post-Corticosteroid FDG-PET Images From Patients Treated With Low Versus High Burst Doses of Prednisone

Pre-treatment position emission tomography (PET) demonstrates 18-fluorodoxyglucose (FDG) uptake subtending 10 segments. Posttreatment PET demonstrates complete resolution of FDG uptake. (B) High burst dose of prednisone. Pre-treatment PET demonstrates FDG uptake subtending 10 segments and much of the right ventricle

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis

Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis

Left Ventricular Intramyocardial Fat Detected on Cardiac Computed Tomography in Patients With Stable Chest Pain Histopathologic studies described subendocardial or transmural intramyocardial fat (IMF) at the site of prior myocardial infarction (MI) (1)

In patients with known prior MI, focal subendocardial or transmural LV-IMF depicted by cardiac CT, has been demonstrated to represent fatty reparation of the MI (3). We aimed to determine the prevalence and association of LV-IMF with cardiovascular (CV) risk and underlying coronary artery disease (CAD) in patients with suspected stable CAD with no history of MI

We compared CV risk and CAD extent between patients with and without LV-IMF. We further determined the extent and severity of coronary artery calcium (CAC) and CAD in IMF-supplying artery versus nonsupplying arteries using a multivariate multilevel mixed-effects model, adjusting for age, sex, body mass index, and ASCVD (Atherosclerotic Cardiovascular Disease) risk score. Finally, we compared the rate of major adverse CV events (CV death, MI, or hospitalization for unstable angina) between patients with and without LV-IMF

CAC >400: 22.5% vs. 12.5%LV-IMF (for any CAC, odds ratio

p ¼ 0.004; and for any CAD, OR: 1.78; 95% CI: CV risk (for CAC >400

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis

The role of serial FDG PET for assessing therapatients from the PROMISE (PRO-PACS-DICOM viewer (RadiAnt

We compared CV risk and CAD extent between patients with and without LV-IMF. We further determined the extent and severity of coronary artery calcium (CAC) and CAD in IMF-supplying artery versus nonsupplying arteries using a multivariate multilevel mixed-effects model, adjusting for age, sex, body mass index, and ASCVD (Atherosclerotic Cardiovascular Disease) risk score. Finally, we compared the rate of major adverse CV events (CV death, MI, or hospitalization for unstable angina) between patients with and without LV-IMF

CAC >400: 22.5% vs. 12.5%LV-IMF (for any CAC, odds ratio

p ¼ 0.004; and for any CAD, OR: 1.78; 95% CI: CV risk (for CAC >400

Lipomatous metaplasia in left ventricular scar

Lipomatous metaplasia in left ventricular scar

Multiparametric cardiac magnetic resonance survey in children with thalassemia major: a multicenter study

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach

Multiparametric cardiac magnetic resonance survey in children with thalassemia major: a multicenter study

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach

allograft rejection (CAR) is one of the most common complications in the first year after orthotopic heart transplantation (OHT) (1)

Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation

Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period

Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures

Biering-Sørensen speaker honoraria from Amgen, Boehringer Ingelheim, Eli Lilly, AstraZeneca, Novo Nordisk, Merck Sharp & Dohme, Sanofi, and Sun Pharma; and research grants were received from Novo Nordisk, Eli Lilly, and Boehringer. Dr. Rossing has received lecture fees from Novo Nordisk; has received consultancy and/or speaking fees (all fees to

Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium

Postsystolic shortening in ischemic myocardium: active contraction or passive recoil?

Post-systolic shortening predicts heart failure following acute coronary syndrome

Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function

Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium

Postsystolic shortening in ischemic myocardium: active contraction or passive recoil?

Post-systolic shortening predicts heart failure following acute coronary syndrome

Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function

© 2020 by the American College of Cardiology Foundation

Herse was supported by the Deutsche Forschungsgemeinschaft (grant HE 6249/5-1). Dr. Golic was a participant of the Clinician Scientist Program funded by the Charité

All other authors have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis

Acute cardiac effects of severe pre-eclampsia

Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Atrial remodeling and atrial fibrillation: recent advances and translational perspectives

Myocardial mechanics in patients with normal LVEF and diastolic dysfunction

© 2020 by the American College of Cardiology Foundation

Herse was supported by the Deutsche Forschungsgemeinschaft (grant HE 6249/5-1). Dr. Golic was a participant of the Clinician Scientist Program funded by the Charité

All other authors have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis

Acute cardiac effects of severe pre-eclampsia

Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Atrial remodeling and atrial fibrillation: recent advances and translational perspectives

Myocardial mechanics in patients with normal LVEF and diastolic dysfunction

Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis

Common pitfalls in statistical analysis: Understanding the properties of diagnostic tests -Part 1

Diagnostic tests 4: likelihood ratios

Biopsy of subcutaneous fatty tissue for diagnosis of systemic amyloidosis

Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis

Common pitfalls in statistical analysis: Understanding the properties of diagnostic tests -Part 1

Diagnostic tests 4: likelihood ratios

Biopsy of subcutaneous fatty tissue for diagnosis of systemic amyloidosis

Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis

Clinical recommendations for cardiovascular magnetic resonance mapping of T1,T2,T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis

Stress-Only Adenosine CMR Improves Diagnostic Yield in Stable Symptomatic Patients With Coronary Artery Calcium

Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update

High-throughput gadobutrol-enhanced CMR: a time and dose optimization study

Comparison of international guidelines for assessment of suspected stable angina: insights from the PROMISE and SCOT-HEART

Prognostic value of coronary CT angiography with selective PET perfusion imaging in coronary artery disease

Anatomical and functional CT for diagnosing hemodynamically significant coronary artery disease: a meta-analysis

for the EVINCI Study Investigators. Multicentre multidevice hybrid imaging study of coronary artery disease: results from the Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population

for the ISCHEMIA Research Group. Initial invasive or conservative strategy for stable coronary disease

National Institute for Health and Care Excellence. Surveillance report 2016-stable angina: management (2011) NICE guideline CG126. London, United Kingdom: National Institute for Health and Care Excellence

Incremental prognostic value of myocardial blood flow quantified with stress dynamic computed tomography perfusion imaging

Coronary CT angiography and 5-year risk of myocardial infarction

Automated pixel-wise quantitative myocardial perfusion mapping by CMR to detect obstructive coronary artery disease and coronary microvascular dysfunction

Magnetic resonance perfusion or fractional flow reserve in coronary disease

ESC guidelines for the diagnosis and management of chronic coronary syndromes

Comprehensive cardiac CT with myocardial perfusion imaging versus functional testing in suspected coronary artery disease

Highsensitivity troponin I and coronary computed tomography in symptomatic outpatients with suspected CAD

Diagnostic performance of hybrid cardiac imaging methods for assessment of obstructive coronary artery disease compared with stand-alone coronary computed tomography angiography

Lesionspecific and vessel-related determinants of fractional flow reserve beyond coronary artery stenosis

Diagnosis of microvascular angina using cardiac magnetic resonance

Effects of statins on coronary atherosclerotic plaques

Diagnostic performance of fully automated pixel-wise quantitative myocardial perfusion imaging by cardiovascular magnetic resonance

State-of-the-art deep learning in cardiovascular image analysis

Changes in myocardial native T1 and T2 after exercise stress

Please note: This work was supported by National Heart, Lung, and Blood Institute (R01HL098237, R01HL098236, R01HL98305, and R01HL098235). The authors are solely responsible for the design and conduct of this study; all study analyses; and the drafting and editing of the paper and its final contents. This paper does not necessarily represent the official views of the National Heart, Lung, and Blood Institute. Dr 

After imaging research, the publication cycle includes peer-review, editorial review, and finally publication. Social media and Altmetrics enable an understanding of the initial (weeks to months) impact of an article, which may have influence on downloads and citations that are measures of impact that become known after months to years. CV ¼ cardiovascular. 

Understanding the relationship of the impact in cardiovascular imaging papers requires the incorporation of Altmetrics, SoMe, and citation impact to assess for the early effects on readership.This review provides a framework to understand how these metrics enable knowledge dissemination through a discussion of the top topics across the field of cardiovascular imaging from 2017 to 2019.This novel framework of Altmetrics, SoMe, and citations may allow the cardiovascular community to further tap into the unreached potential of SoMe to accelerate the translation of future research to global audiences. Please note: The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Imaging author instructions page.

We thank Dr. Aimo and colleagues for their interest in our study (1) . Regarding the variability of native T1 across different sites, we fully agree that local reference ranges are needed. We would go further and highlight the importance of phantom quality control to ensure drift between the time of reference range creation and scanning (2) . The authors highlight the use of a single region in the midseptum. We agree that such a method is only suitable for diffuse disease. This was Please note: yDrs. Baggiano and Boldrini contributed equally to this work. The authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Imaging author instructions page.